Dental Monitoring strengthens its leading position in AI-powered tele dentistry by acquiring Loum, a European health tech start-up
5.5.2020 20:48:00 EEST | Business Wire | Press release
Dental Monitoring has acquired Loum, "the digital assistant for patients and healthcare professionals.” Founded in 2017, Loum's objective is to ensure that patients perceive their healthcare positively, and not as a burden. Their innovative developments, in particular an application designed to improve the patient experience, complements Dental Monitoring’s expansive suite of AI-driven tools. The app implements a playful and dynamic system that facilitates the doctor-patient relationship and allows patients to engage fully with their treatment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200505005871/en/
(Photo: Business Wire)
"We are delighted with the acquisition of Loum, which allows us to integrate complementary skills into our teams and meet the expectations of patients and their doctors worldwide. We are coordinating a robust solution and collaborating with a team of skilled colleagues who will enhance our AI-powered platform with new strategies and an innovative approach. Ultimately, we want to design a more playful version of our patient application, and through Loum’s gamification approach, which allows for careful monitoring of treatment, this is an angle that we are now addressing," says Philippe Salah, CEO of the Dental Monitoring.
"Placing gaming at the heart of the healthcare protocol not only brings a little lightness to the patient’s journey, but also makes any follow-up care much more appealing, accessible, and more likely to be followed,” explains Michaël Sutter, CEO of Loum.
"Joining Dental Monitoring is great news for us and our customers. We now offer them the possibility of benefitting from a broader range of cutting-edge solutions for the management of their patients’ care, while continuing to provide them with personalized and local support. This integration is also an accelerator in terms of innovation and is therefore in line with a product offering that remains at the forefront of market expectations. We are delighted to bring our vision of the patient journey and to partner with those who share our taste for service and excellence," announced Michaël Sutter, CEO, and Clément Coicault, COO of Loum.
###
About Dental Monitoring:
Founded in 2015 by Philippe Salah, Dental Monitoring is the first AI-based company to target dental professionals and improve the care they provide their patients.
Dental Monitoring solutions are created to assist dental professionals throughout their patients’ journeys by:
● Simplifying the connection between dental professionals and patients
● Facilitating follow-ups and providing an easier virtual experience during treatment
● Improving treatment stability and results over time
Dental Monitoring is present across Europe, the United States and Asia Pacific. It has 250 employees and 5 offices (Paris, Austin - Texas, London, Hong Kong and Sydney).
Dental Monitoring is changing the way dental and orthodontic professionals care for patients. If you would like more information about Loum and this acquisition, or about the Dental Monitoring’s full suite of tele dentistry solutions, please visit www.dental-monitoring.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200505005871/en/
Contact information
Press Contact: Charlotte Garzino – c.garzino@dental-monitoring.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kerecis Drives the Fish-Skin Conversation at Leading European Wound Conference - EWMA-DEWU 20264.5.2026 21:25:00 EEST | Press release
Kerecis, the company pioneering the use of sustainably sourced intact fish skin in cellular therapy and tissue regeneration, will play a prominent scientific and educational role at the EWMA‑DEWU 2026 Conference, taking place May 6–8 at the Messe & Congress Centrum Bremen in Bremen, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260504487743/en/ MariCell® Solid This year, The European Wound Management Association's (EWMA) meeting is held in conjunction with the Deutscher Wundkongress (DEWU); combining two major wound-care congresses into a single forum for scientific exchange, education, and clinical discussion. At this year’s conference, Kerecis will highlight growing clinical experience with intact fish‑skin grafts across a broad range of wound indications, supported by two Kerecis‑led scientific symposia, multiple oral and poster presentations, and direct engagement with clinicians at Booth D30, located adjacent
Printing the Future of Medicine: CTIBIOTECH™ Announces $27 Million Investment to Launch U.S. Operations at the SelectUSA Investment Summit4.5.2026 21:00:00 EEST | Press release
CTIBIOTECH™, a pioneering Contract Research, Development, and Manufacturing Organization (CRDMO) and global leader in 3D bioprinting of human tissues, today officially announces the launch of its North American subsidiary, CTIBIOTECH USA™. The official launch took place today at the prestigious SelectUSA Investment Summit in Washington, D.C. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260504107996/en/ From Biopsy to Breakthrough, CTIBIOTECH USA™'s Vision for Precision Medicine Operating from its new United States base in the thriving life sciences “Cellicon Valley” hub of Philadelphia, Pennsylvania, in association with BioLabs for Advanced Therapeutics, CTIBIOTECH USA™ will provide the company's proprietary human cell and tissue bioassays and New Approach Methods (NAMs) directly to North American pharmaceutical, biomedical, and dermatocosmetics markets. By producing and supplying these cutting-edge human bioassays domesti
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 18:16:00 EEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 17:28:00 EEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 16:00:00 EEST | Press release
Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading transformative and meaningful customer experiences. These leading organizations are turning everyday interactions into seamless, cross-channel journeys that deliver meaningful business impact and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom